Xin Han

机构：Hebei Medical University, Shandong University of Traditional Chinese Medicine, Shanghai Jiao Tong University, South China Normal University, Ministry of Education, Fourth Hospital of Hebei Medical University, Second Affiliated Hospital of Zhejiang University, Zhejiang University · ORCID：0000-0001-5282-9927

发表论文 27 篇 · 总被引 154 次 · h-index 8

代表论文

• Fam118B, a novel component in Cajal bodies, is required for Cajal body formation, snRNP biogenesis and cell viability (2014 · Journal of Cell Science · 被引 23)
• Dietary patterns in the progression of metabolic dysfunction-associated fatty liver disease to advanced liver disease: a prospective cohort study (2024 · American Journal of Clinical Nutrition · 被引 20)
• Downregulation of snoRNA SNORA52 and Its Clinical Significance in Hepatocellular Carcinoma (2021 · BioMed Research International · 被引 19)
• Identification of snoRNA SNORA71A as a Novel Biomarker in Prognosis of Hepatocellular Carcinoma (2020 · Disease Markers · 被引 17)
• Systemic Sequential Therapy of CisGem, Tislelizumab, and Lenvatinib for Advanced Intrahepatic Cholangiocarcinoma Conversion Therapy (2021 · Frontiers in Oncology · 被引 14)
• Down-regulation of small nuclear RNA (snRNA) RNU5E-1 in hepatocellular carcinoma presents with vital clinical significance (2020 · Journal of Gastrointestinal Oncology · 被引 9)